Radiation Oncology · 2013 · 17 citations · 20 references
MedicineOncologyRadiation OncologyClinical Radiation OncologySurgical OncologyTreatment PlanningRadiation TherapyRadiation Treatment PlanningDistant Metastasis-free SurvivalKaplan-meier Confidence IntervalsKaplan-meier Survival EstimatesOncologic Outcomes AssessmentPrimary Tumor AssessmentTumor Volume EstimationTumor Volume Measurement
BACKGROUND: The combined predictive value of plasma uric acid and primary tumor volume in nasopharyngeal carcinoma (NPC) patients receiving intensity modulated radiation therapy (IMRT) has not yet been determined. METHODS: In this retrospective study, plasma uric acid level was measured after treatment in 130 histologically-proven NPC patients treated with IMRT. Tumor volume was calculated from treatment planning CT scans. Overall (OS), progression-free (PFS) and distant metastasis-free (DMFS) survival were compared using Kaplan-Meier analysis and the log rank test, and Cox multivariate and univariate regression models were created. RESULTS: Patients with a small tumor volume (<27 mL) had a significantly better DMFS, PFS and OS than patients with a large tumor volume. Patients with a high post-treatment plasma uric acid level (>301 μmol/L) had a better DMFS, PFS and OS than patients with a low post-treatment plasma uric acid level. Patients with a small tumor volume and high post-treatment plasma uric acid level had a favorable prognosis compared to patients with a large tumor volume and low post-treatment plasma uric acid level (7-year overall OS, 100% vs. 48.7%, P <0.001 and PFS, 100% vs. 69.5%, P <0.001). CONCLUSIONS: Post-treatment plasma uric acid level and pre-treatment tumor volume have predictive value for outcome in NPC patients receiving IMRT. NPC patients with a large tumor volume and low post-treatment plasma uric acid level may benefit from additional aggressive treatment after IMRT.
20
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text
B N Ames, Richard Cathcart, Elizabeth Schwiers et al. · Proceedings of the National Academy of Sciences · 1981 · 2.9K citations · Full text
Nancy Lee, Jonathan Harris, Adam S. Garden et al. · Journal of Clinical Oncology · 2009 · 709 citations · Full text
Lei Chen, Chaosu Hu, Xiao-Zhong Chen et al. · The Lancet Oncology · 2011 · 564 citations